Metraipolis › archive › dc_7e378c9c3dca

Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions — Europe PMC PMID:42449597

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449597
DOI
10.3390/cancers18132051
License (as archived)
solo-consultazione
Archived
2026-10-19T05:04:38.763Z
SHA-256 of the archived text
a86cf1695cb7861c8749f288d5cb4e9aa1d4f0fe99fd620f06dede204c057fae
Stable URL of this page
https://metraipolis.com/documento/dc_7e378c9c3dca

How to cite

Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions — Europe PMC PMID:42449597 — Europe PMC (en), https://europepmc.org/article/MED/42449597 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e378c9c3dca (Metraipolis archive dc_7e378c9c3dca, sha256 a86cf1695cb7861c8749f288d5cb4e9aa1d4f0fe99fd620f06dede204c057fae)
BibTeX
@misc{dc7e378c9c3dca,
  title = {Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions — Europe PMC PMID:42449597},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449597},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e378c9c3dca; sha256 a86cf1695cb7861c8749f288d5cb4e9aa1d4f0fe99fd620f06dede204c057fae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449597. Agents can read the archived copy with the MCP tool read_document.